Literature DB >> 21365283

Familial spinal neurofibromatosis due to a multiexonic NF1 gene deletion.

Antonio Pizzuti1, Irene Bottillo, Francesca Inzana, Valentina Lanari, Francesca Buttarelli, Isabella Torrente, Anna Teresa Giallonardo, Alessandro De Luca, Bruno Dallapiccola.   

Abstract

We report the detailed clinical presentation and molecular features of a spinal neurofibromatosis familial case where a 40-year-old woman, presenting with multiple bilateral spinal neurofibromas and no other clinical feature of neurofibromatosis type 1 (NF1), inherited a paternal large multiexonic deletion (c.5944-?_7126+?del) which resulted in NF1 gene haploinsufficiency at the RNA level. In the clinically unaffected 73-year-old father, spinal cord MRI disclosed bilateral and symmetrical hypertrophy of spinal lumbosacral roots. Our study widens the phenotypic and mutational spectrum of NF1 and illustrates the difficulties of counseling patients with border-line or atypical presentation of this disorder.

Entities:  

Mesh:

Year:  2011        PMID: 21365283     DOI: 10.1007/s10048-011-0278-5

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  34 in total

1.  NF1 mutations and clinical spectrum in patients with spinal neurofibromas.

Authors:  L Kluwe; M Tatagiba; C Fünsterer; V-F Mautner
Journal:  J Med Genet       Date:  2003-05       Impact factor: 6.318

2.  Independent NF1 mutations in two large families with spinal neurofibromatosis.

Authors:  L Messiaen; V Riccardi; J Peltonen; O Maertens; T Callens; S L Karvonen; E-L Leisti; J Koivunen; I Vandenbroucke; K Stephens; M Pöyhönen
Journal:  J Med Genet       Date:  2003-02       Impact factor: 6.318

Review 3.  Neurofibromatosis: clinical heterogeneity.

Authors:  V M Riccardi
Journal:  Curr Probl Cancer       Date:  1982-08       Impact factor: 3.187

Review 4.  Neurofibromatosis type 1: A model condition for the study of the molecular basis of variable expressivity in human disorders.

Authors:  J C Carey; D H Viskochil
Journal:  Am J Med Genet       Date:  1999-03-26

5.  Loss of heterozygosity at the BRCA2 locus detected by multiplex ligation-dependent probe amplification is common in prostate cancers from men with a germline BRCA2 mutation.

Authors:  Amber J Willems; Sarah-Jane Dawson; Hema Samaratunga; Alessandro De Luca; Yoland C Antill; John L Hopper; Heather J Thorne
Journal:  Clin Cancer Res       Date:  2008-04-29       Impact factor: 12.531

6.  The spectrum of somatic and germline NF1 mutations in NF1 patients with spinal neurofibromas.

Authors:  Meena Upadhyaya; Gill Spurlock; Lan Kluwe; Nadia Chuzhanova; Emma Bennett; Nick Thomas; Abhijit Guha; Victor Mautner
Journal:  Neurogenetics       Date:  2009-02-17       Impact factor: 2.660

7.  CT imaging in adults with neurofibromatosis-1: frequent asymptomatic plexiform lesions.

Authors:  J H Tonsgard; S M Kwak; M P Short; A H Dachman
Journal:  Neurology       Date:  1998-06       Impact factor: 9.910

8.  Genomic organization of the neurofibromatosis 1 gene (NF1).

Authors:  Y Li; P O'Connell; H H Breidenbach; R Cawthon; J Stevens; G Xu; S Neil; M Robertson; R White; D Viskochil
Journal:  Genomics       Date:  1995-01-01       Impact factor: 5.736

9.  Deletions of NF1 gene and exons detected by multiplex ligation-dependent probe amplification.

Authors:  A De Luca; I Bottillo; M C Dasdia; A Morella; V Lanari; L Bernardini; L Divona; S Giustini; L Sinibaldi; A Novelli; I Torrente; A Schirinzi; B Dallapiccola
Journal:  J Med Genet       Date:  2007-12       Impact factor: 6.318

10.  Characterization of the somatic mutational spectrum of the neurofibromatosis type 1 (NF1) gene in neurofibromatosis patients with benign and malignant tumors.

Authors:  Meena Upadhyaya; Song Han; Claudia Consoli; Elisa Majounie; Martin Horan; Nick S Thomas; Christopher Potts; Sian Griffiths; Martino Ruggieri; Andreas von Deimling; David N Cooper
Journal:  Hum Mutat       Date:  2004-02       Impact factor: 4.878

View more
  2 in total

1.  Spinal neurofibromatosis associated with classical neurofibromatosis type 1: genetic characterisation of an atypical case.

Authors:  Kursat bora Carman; Ayten Yakut; Banu Anlar; Sukriye Ayter
Journal:  BMJ Case Rep       Date:  2013-02-14

2.  Can the diagnosis of NF1 be excluded clinically? A lack of pigmentary findings in families with spinal neurofibromatosis demonstrates a limitation of clinical diagnosis.

Authors:  Emma Mm Burkitt Wright; Emma Sach; Saba Sharif; Oliver Quarrell; Thomas Carroll; Richard W Whitehouse; Meena Upadhyaya; Susan M Huson; D Gareth R Evans
Journal:  J Med Genet       Date:  2013-06-28       Impact factor: 6.318

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.